A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2011
12/28/2011	EP2398795A1 Heteroaryl substituted pyridazinone derivatives
12/28/2011	EP2398794A1 Hepatitis c virus inhibitors
12/28/2011	EP2398793A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
12/28/2011	EP2398792A1 Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of copd
12/28/2011	EP2398791A1 INDOLE/BENZIMIDAZOLE COMPOUNDS AS mTOR KINASE INHIBITORS
12/28/2011	EP2398790A1 Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
12/28/2011	EP2398789A1 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
12/28/2011	EP2398786A1 4 -isopropylphenyl glucitol compounds as sglt1 inhibitors
12/28/2011	EP2398784A1 Crystalline forms of febuxostat
12/28/2011	EP2398783A1 Carboxamide compounds and their use as calpain inhibitors
12/28/2011	EP2398782A1 Isoxazole-isoxazole and isoxazole-isothiazole derivatives
12/28/2011	EP2398781A1 1,4-benzodiazepin-2-on derivatives
12/28/2011	EP2398780A1 Cyclopropyl amide derivatives targeting the histamine h3 receptor
12/28/2011	EP2398776A1 Functionally selective alpha2c adrenoreceptor agonists
12/28/2011	EP2398772A1 5- (2-{ ý6- (2, 2-difluoro-2-phenylethoxy) hexyl¨amino}-l-hydroxyethyl) -8-hydroxyquin olin-2 (1h)-one and its use in the treatment of pulmonary diseases
12/28/2011	EP2398771A2 Heterocyclic compounds which modulate the cb2 receptor
12/28/2011	EP2398769A1 Novel ortho-aminoamides for the treatment of cancer
12/28/2011	EP2398768A1 Pyrrolidine derivatives as nk3 receptor antagonists
12/28/2011	EP2398760A1 Allosteric binding compounds
12/28/2011	EP2398560A1 Methods for treating lipomas and liposarcomas
12/28/2011	EP2398559A1 Pharmaceutical compositions and methods for treating tuberculosis
12/28/2011	EP2398558A1 Amine or amino alcohols as glyt1 inhibitors
12/28/2011	EP2398491A1 Sphingosine 1-phosphate antagonism
12/28/2011	EP2398489A2 Composition comprising n2 - (1-oxohexadecyl) - lysyl - valyl - lysine for treating rosacea and its symptoms
12/28/2011	EP2398482A2 Methods and compositions for inhibiting cellular proliferation and surgical adhesion
12/28/2011	EP2398481A2 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
12/28/2011	EP2398480A1 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
12/28/2011	EP2398479A2 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
12/28/2011	EP2398478A1 Cajanus extracts and glucosamine for inflammatory disorders
12/28/2011	EP2398477A1 Methods of and compositions for reducing cell death
12/28/2011	EP2398476A1 Policosanol nanoparticles
12/28/2011	EP2398475A1 Pharmaceutical preparation and delivery system
12/28/2011	EP2398474A1 Inhibitors of hcv ns5a
12/28/2011	EP2398473A1 5- (2-{ ý6- (2, 2-difluoro-2-phenylethoxy) hexyl¨amino} -1-hydroxyethyl) -8-hydroxyquinolin-2 (ih)-one for the treatment of lung function
12/28/2011	EP2398472A2 Methods and preparations for protecting critically ill patients with a polyamine (e.g. spermine, spermidine)
12/28/2011	EP2398471A2 Use of resveratrol or another hydroxylated stilbene for preserving cognitive functioning
12/28/2011	EP2398468A1 Pharmaceutical compositions comprising prasugrel base or its pharmaceutically acceptable acid addition salts and processes for their preparation
12/28/2011	EP2398467A1 Particles comprising drospirenone encapsulated in a polymer
12/28/2011	EP2398466A2 Methods and compositions for localized agent delivery
12/28/2011	EP2398465A1 A dermaceutical gel made using sodium fusidate&a process to make it
12/28/2011	EP2398463A1 A method for amphiphilic drug loading in liposomes by ion gradient
12/28/2011	EP2398462A1 Ph-modulated formulations for pulmonary delivery
12/28/2011	EP2398461A1 Formulation comprising drospirenone for subcutaneous or intramuscular administration
12/28/2011	EP2398459A2 Transdermal delivery of diclofenac, carbamazepine and benzydamine
12/28/2011	EP2398458A1 Pharmaceutical composition containing microcolloidal silver and carboxymethyl beta glucan for disinfection of the nasal mucosae, and process for preparation thereof
12/28/2011	EP2398443A2 Storage stable prostaglandin product
12/28/2011	EP2398339A1 Compositions and methods for feeding poultry
12/28/2011	EP2398325A1 Methods of treating intestinal diseases and inflammatory conditions related to hiv-aids
12/28/2011	EP2398324A1 PYRAZOLO [4,3-c]CINNOLIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
12/28/2011	EP2398323A1 Novel hetero pyrrole analogs acting on cannapinoid receptors
12/28/2011	EP2398322A1 Estrogen receptor ligands and methods of use thereof
12/28/2011	EP2398321A1 Iminosugars and methods of treating viral diseases
12/28/2011	EP2398320A1 Amidobipiperidinecarboxylate m1 allosteric agonists, analogs and derivatives thereof, and methods of making and using same
12/28/2011	EP2398319A1 Therapeutic compositions and methods for treating chronic kidney disease associated with a metabolic imbalance
12/28/2011	EP2385071A9 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases related to beclin-1
12/28/2011	EP2296668B1 Compositions for the treatment of hair loss
12/28/2011	EP2291185B1 Octenidine composition
12/28/2011	EP2257275B1 Ketorolac tromethamine compositions for treating or preventing ocular pain
12/28/2011	EP2245023B1 Heterocyclic antiviral compounds
12/28/2011	EP2205560B1 Azabicyclo [3. 1. 0]hexyl derivatives as modulators of dopamine d3 receptors
12/28/2011	EP2200980B9 Amino arylsulfonamide compounds and their use as 5-ht6 ligands field of invention
12/28/2011	EP2197843B1 Piperidine derivatives as agonists of muscarinic receptors
12/28/2011	EP2195323B1 Polyspirane compounds, use thereof in the treatment of malaria or toxoplasmosis and method for their preparation
12/28/2011	EP2178858B1 Novel heterocyclic compounds as mglu5 antagonists
12/28/2011	EP2178851B1 Compounds and methods for modulating fxr
12/28/2011	EP2170876B1 Pharmaceutical composition for prevention and treatment of restenosis comprising isoxazole derivatives
12/28/2011	EP2170332B1 A medicament for treating glaucoma comprising as an active ingredient cyclodextrin-clathrate compound of cilostazol
12/28/2011	EP2170103B1 Cachexia prevention supplement
12/28/2011	EP2162019B1 Lipid composition for improving brain function
12/28/2011	EP2154971B1 A synergistic pharmaceutical combination for the treatment of cancer
12/28/2011	EP2125831B1 Oxazinyl isoflavonoid compounds, medicaments and use
12/28/2011	EP2091328B1 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
12/28/2011	EP2077719B1 Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
12/28/2011	EP2070536B1 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent
12/28/2011	EP2010537B1 Imidazoquinoxaline compounds as immunomodulators
12/28/2011	EP1993560B1 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
12/28/2011	EP1981871B1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
12/28/2011	EP1971341B1 Use of morpholino compounds for the treatment of halitosis
12/28/2011	EP1928451B1 Methods for treating substance-related disorders
12/28/2011	EP1922307B1 Heterocyclic inhibitors of mek and methods of use thereof
12/28/2011	EP1896025B1 Scopolamine for the treatment of depression and anxiety
12/28/2011	EP1888083B1 Compositions and their uses directed to lmw-ptpase
12/28/2011	EP1873240B1 hTERT GENE EXPRESSION REGULATORY GENE
12/28/2011	EP1872783B1 Therapeutic agent for corneal/conjunctival disorder
12/28/2011	EP1871391B1 Endogenous retrovirus and proteins encoded by env as a target for cancer treatment
12/28/2011	EP1866297B1 Process for producing an aminomethyl thiazole compound
12/28/2011	EP1857120B1 Infusion for mastitis
12/28/2011	EP1782804B1 MEDICINAL COMPOSITION, COMPRISING A HMG-CoA REDUCTASE INHIBITOR AND AN AMINO ALCOHOL DERIVATIVE, AS IMMUNOSUPPRESSANT
12/28/2011	EP1773362B1 Solvent based plant extracts
12/28/2011	EP1753414B1 Novel use of peptide compounds for treating dyskinesia
12/28/2011	EP1748767B1 1-(3-methyl-2,4-dimethoxyphenyl)-3-(2',4'-dihydroxyphenyl)-propane as a potent tyrosinase inhibitor
12/28/2011	EP1742644B1 Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabine
12/28/2011	EP1697348B1 Hiv protease inhibiting compounds
12/28/2011	EP1664036B1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity
12/28/2011	EP1653951B1 Benzimidazole derivatives as raf kinase inhibitors
12/28/2011	EP1640022B1 Menthol-containing preparation
12/28/2011	EP1596828B1 Lipophilic drug delivery vehicle and methods of use thereof
12/28/2011	EP1556027B1 Modified amino acid 5-cnac for the inhibition of platelet aggregation
12/28/2011	EP1523303B1 Medicaments containing vardenafil hydrochloride trihydrate and processes for the manufacture thereof
12/28/2011	EP1443920B1 Preparation for improving the action of receptors

1 ... 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 ... 7860